NAACCR Item #3818: CA-125 Pretreatment Interpretation
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3818 | 1 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | ca125PretreatmentInterpretation | Tumor |
Alternate Names
- : CA-125 (Carbohydrate Antigen 125) Pretreatment Interpretation
Required Status:
NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Required, site specific
CCCR Collect: Required, site specific; when available
Description
Carbohydrate Antigen 125 (CA-125) is a tumor marker that is useful for following the response to therapy in patients with ovarian cancer, who may have elevated levels of this marker.
Rationale
Preoperative CA-125 is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF# 1.
Allowable Values
0-2, 7-9
Codes
| Code | Description |
|---|---|
| 0 | Negative/normal; within normal limits |
| 1 | Positive/elevated |
| 2 | Stated as borderline; undetermined whether positive or negative |
| 7 | Test ordered, results not in chart |
| 8 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error) |
| 9 | Not documented in medical record CA-125 not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.